Recruiting · registry status

Virtual reality for movement and thinking together

This study tests guided virtual reality activities that combine movement and thinking in people with Parkinson's.

Testing a treatment or activity · Study reference: JPRN-UMIN000056111

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Results reported

Start (reported date): 2024-11-07
Study finished (reported date): 2027-03-31

Planned dates can move. A study finishing does not tell us when a paper will be published.

Read the results reported in the registry

Changes we have recorded

2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Age range not listed · Ask the team who can join

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: male and female

Inclusion criteria: Patients who meet all of the following criteria will be considered. 1) Patients who have been diagnosed with Parkinson's disease at Hoehn & Yahr Classification Stage III 2) Patients who have not required medication adjustments for symptom fluctuations in the past month 3) Patients with a consciousness level of JCS 0-10 and amenable to follow-up 4) Patients who can be intervened in the training room in a wheelchair sitting position 5) Patients with physical dysfunction (ataxia, gait and balance problems, upper limb dysfunction, dysarthria, dysphagia, etc.) or cognitive dysfunction (higher brain dysfunction, attention disorder, hemispatial neglect, etc.) 6) Patients who have obtained written consent for participation in the study from the patient or a surrogate (relative up to the fifth degree of kinship) within 10 days of the start of the intervention in the training room after fulfilling 1)-5) above. Exclusion criteria: Those deemed inappropriate for participation in the study by the principal investigator or research associate

Full study name & original research details

Official study title

Randomized Controlled Trial on the Clinical Effectiveness of Somato-Cognitive Coordination Therapy using mediVR KAGURA in Parkinson's Disease at Hoehn & Yahr Classification Stage III - RCT of Somato-Cognitive Coordination Therapy using mediVR KAGURA in Parkinson's Disease at Hoehn & Yahr Classification Stage III

Short title used by the registry

Randomized Controlled Trial on the Clinical Effectiveness of Somato-Cognitive Coordination Therapy using mediVR KAGURA in Parkinson's Disease at Hoehn & Yahr Classification Stage III

Original description

Intervention: Patients who meet all of the following criteria who are randomly assigned to the group using the mediVR Kagura. 1) Patients who have been diagnosed with Parkinson's disease at Hoehn & Yahr Classification Stage III 2) Patients who have not required medication adjustments for symptom fluctuations in the past month 3) Patients with a consciousness level of JCS 0-10 and amenable to follow-up 4) Patients who can be intervened in the training room in a wheelchair sitting position 5) Patients with physical dysfunction (ataxia, gait and balance problems, upper limb dysfunction, dysarthria, dysphagia, etc.) or cognitive dysfunction (higher brain dysfunction, attention disorder, hemispatial neglect, etc.) 6) Patients who have obtained written consent for participation in the study from the patient or a surrogate (relative up to the fifth degree of kinship) within 10 days of the start of the intervention in the training room after fulfilling 1)-5) above. Patients who meet all of the following criteria who are randomly assigned to the group that does not use the mediVR Kagura. 1) Patients who have been diagnosed with Parkinson's disease at Hoehn & Yahr Classification Stage III 2) Patients who have not required medication adjustments for symptom fluctuations in the past month 3) Patients with a consciousness level of JCS 0-10 and amenable to follow-up 4) Patients who can be intervened in the training room in a wheelchair sitting position 5) Patients with physical dysfunction (ataxia, gait and balance problems, upper limb dysfunction, dysarthria, dysphagia, etc.) or cognitive dysfunction (higher brain dysfunction, attention disorder, hemispatial neglect, etc.) 6) Patients who have obtained written consent for participation in the study from the patient Primary outcome: The following indicators are measured and evaluated at the beginning of rehabilitation in the training room and 2 weeks after the start of rehabilitation. Common assessment measures: Functional Independence Measure (FIM), Stroke impairment Assessment Set (SIAS), 10-meter walk test, Timed up and go test (TUG), Brunnstrom Stages (BRST), Fugl-Meyer Assessment (FMA), Motor Activity Log (MAL), Box and Block Test (BBT), Mini-Mental State Examination (MMSE), Frontal Assessment Battery (FAB), and Trail Making Test (TMT). Patients with ataxia: Scale for the Assessment and Rating of Ataxia (SARA). Patients with attention disorders: line and star blotting. Patients with dysarthria: Assessment of Motor Speech for Dysarthria (AMSD), Oral diadochokinesis: Scale for Contraversive pushing (SCP). Other measures deemed necessary by the investigator.

Conditions reported: Parkinson's Disease at Hoehn & Yahr Classification Stage III

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

JPRN · JPRN-UMIN000056111 ↗ — Recruiting; WHO ICTRP processed 2026-06-29; checked 2026-10-11

Study type: Interventional
Interventions: Patients who meet all of the following criteria who are randomly assigned to the group using the mediVR Kagura. 1) Patients who have been diagnosed with Parkinson's disease at Hoehn & Yahr Classification Stage III 2) Patients who have not required medication adjustments for symptom fluctuations in the past month 3) Patients with a consciousness level of JCS 0-10 and amenable to follow-up 4) Patients who can be intervened in the training room in a wheelchair sitting position 5) Patients with physical dysfunction (ataxia, gait and balance problems, upper limb dysfunction, dysarthria, dysphagia, etc.) or cognitive dysfunction (higher brain dysfunction, attention disorder, hemispatial neglect, etc.) 6) Patients who have obtained written consent for participation in the study from the patient or a surrogate (relative up to the fifth degree of kinship) within 10 days of the start of the intervention in the training room after fulfilling 1)-5) above. Patients who meet all of the following criteria who are randomly assigned to the group that does not use the mediVR Kagura. 1) Patients who have been diagnosed with Parkinson's disease at Hoehn & Yahr Classification Stage III 2) Patients who have not required medication adjustments for symptom fluctuations in the past month 3) Patients with a consciousness level of JCS 0-10 and amenable to follow-up 4) Patients who can be intervened in the training room in a wheelchair sitting position 5) Patients with physical dysfunction (ataxia, gait and balance problems, upper limb dysfunction, dysarthria, dysphagia, etc.) or cognitive dysfunction (higher brain dysfunction, attention disorder, hemispatial neglect, etc.) 6) Patients who have obtained written consent for participation in the study from the patient
Phases: Not selected
Sponsor: National Hospital Organization Maizuru Medical Center
Start date reported by registry: 2024-11-07 (reported)

Registry updated: Not reported · Status last verified by the registry submitter: Not reported

Registry records retrieved 2026-10-11 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Yuta Oi · 0773622680 · 406-maizuru-mc@mail.hosp.go.jp

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Facility not reported

Japan

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.